高级检索

恶性肠梗阻的治疗

陈彻, 李幼生

陈彻, 李幼生. 恶性肠梗阻的治疗[J]. 实用临床医药杂志, 2005, (9): 43-45. DOI: 10.3969/j.issn.1672-2353.2005.09.008
引用本文: 陈彻, 李幼生. 恶性肠梗阻的治疗[J]. 实用临床医药杂志, 2005, (9): 43-45. DOI: 10.3969/j.issn.1672-2353.2005.09.008
shu
CHEN Che, LI You-sheng. The treatment for vicious ileus[J]. Journal of Clinical Medicine in Practice, 2005, (9): 43-45. DOI: 10.3969/j.issn.1672-2353.2005.09.008
Citation: CHEN Che, LI You-sheng. The treatment for vicious ileus[J]. Journal of Clinical Medicine in Practice, 2005, (9): 43-45. DOI: 10.3969/j.issn.1672-2353.2005.09.008
shu

恶性肠梗阻的治疗

  • 南京军区南京总医院,全军普通外科研究所,江苏,南京,210002

详细信息

  • 中图分类号: R574.2

The treatment for vicious ileus

摘要

    摘要
  • 摘要: 晚期癌症患者,尤其是腹部或盆腔肿瘤的患者,肠梗阻是常见的并发症,此种肠梗阻一般称为恶性肠梗阻(MBO).晚期妇科恶性肿瘤患者肠梗阻的发生率为5%～51%,其中尤以卵巢癌患者常见,且常是致患者死亡的原因[1].晚期结肠癌、直肠癌肠梗阻的发生率为4%～24%.恶性肠梗阻可以由肿瘤本身引起(腔内或腔外肿瘤生长),也可能由于良性原因引起,如肠粘连、放疗后肠损伤、炎性肠病和内疝.在结肠癌、直肠癌中,良性病因引起的肠梗阻占了一半,而在妇科肿瘤中仅占6%[2].胃肠道肿瘤由于单纯肿瘤阻塞导致的肠梗阻、可手术治愈者不在本文讨论之列.
    • HTML全文
    • 参考文献(21)
  • Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction [J]. International Journal of Gynecological Cancer, 2002(2):135.
    Carla R, Robert T, Mary B. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer [J]. SUPPORTIVE CARE IN CANCER, 2001.223.
    Fainsinger R L, Spachynski K, Hanson J. Symptom control in terminally ill patients with malignant bowel obstruction [J]. Journal of Pain and Symptom Management, 1994.12.doi: 10.1016/0885-3924(94)90141-4.
    Ventafridda V, Ripamonti C, Caraceni A. The management of inoperable gastroin-testinal obstruction in terminal cancer patients [J]. Tumori, 1990.389.
    Mercadante S. Pain in inoperable bowel obstruction [J]. Pain Digest, 1995.9.
    Feuer D J, Broadley K E, Shepherd J H, Barton D P. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer [J]. Gynecologic Oncology, 1999, (3):313.
    Higashi H, Shida H, Ban K, Yamagata S Masuda K Imanari T Yamamoto T. Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer [J]. Japanese Journal of Clinical Oncology, 2003(7):357.doi: 10.1093/jjco/hyg061.
    Blair S L, Chu D Z, Schwarz R E. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer [J]. Annals of Surgical Oncology, 2001(8):632.doi: 10.1007/s10434-001-0632-1.
    Woolfson R G, Jennings K, Whalen G F. Management of bowel obstruction in patients with abdominal cancer [J]. Archives of Surgery, 1997.1093.
    Harris G J C, Senagore A J, Lavery I C, Fazio V W. The management of neoplastic colorectal obstruction with colonic endoluminal stenting devices [J]. American Journal of Surgery, 2001, (6):499.doi: 10.1016/S0002-9610(01)00622-5.
    Soetikno R M, Carr-Locke D L. Expandable metal stents for gastric outlet, duodenal, and small intestinal obstruction [J]. Gastrointestinal Endoscopy Clinics of North America, 1999.447.
    Campagnutta E, Cannizzaro R. Percutaneous endoscopic gastrostomy(PEG) in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer:a review [J]. European Journal of Gynaecological Oncology, 2000.397.
    Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F, Casuccio A. Role of octreotide, scopolamine butylbromide and hydration in symptom control of patients with inoperable bowel obstruction having a nasogastric tube.A prospective randomized clinical trial [J]. Journal of Pain and Symptom Management, 2000, (1):23.doi: 10.1016/S0885-3924(99)00147-5.
    Mercadante S, Ripamonti C, Casuccio A, Zecca E, Groff L. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction [J]. Supportive Care in Cancer, 2000.188.
    Fainsinger R L, Spachynski K, Hanson J. Symptom control in terminally ill patients with malignant bowel obstruction [J]. Journal of Pain and Symptom Management, 1994.12.doi: 10.1016/0885-3924(94)90141-4.
    Twycross R, Back I. Nausea and vomiting in advanced cancer [J]. Eur J Palliat Care, 1998.39.
    Mercadante S. Pain in inoperable bowel obstruction [J]. Pain Digest, 1995.9.
    McCann R M, Hall W J, Groth-Juncker A. Comfort care for terminally ill patients.The appropriate use of nutrition and hydration [J]. Journal of the American Medical Association, 1994.1263.
    Philip J, Depczynski B. The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy [J]. Journal of Pain and Symptom Management, 1997.104.doi: 10.1016/S0885-3924(96)00269-2.
    Bozzetti F, Amadori D, Bruera E, Cozzaglio L, Corli O, Filiberti A. Guidelines on artificial nutrition versus hydration in terminal cancer patients [J]. Nutrition, 1996.163.doi: 10.1016/S0899-9007(96)91120-X.
    Cozzaglio L, Balzola F, Cosentino F. Outcome of cancer patients receiving home parenteral nutrition [J]. Journal of Parenteral and Enteral Nutrition, 1997.339.
    • 相关文章
    • 施引文献(15)

  • 期刊类型引用(14)

    1. 何林怡，龚晓雪，宋丹丹，杨红灵. 宫颈癌筛查异常人群实施阴道镜下宫颈活检的准确性及漏诊因素分析. 中国药物滥用防治杂志. 2025(01): 38-40+54 . 百度学术
    2. 陆安. 阴道镜联合TCT、HPV检查对宫颈癌及宫颈鳞状上皮内病变的诊断价值. 系统医学. 2023(01): 167-170 . 百度学术
    3. 刘钰，王君梅. 阴道镜下宫颈活检诊断宫颈上皮内瘤变的准确性及其漏诊宫颈癌的影响因素. 贵州医药. 2022(01): 137-138 . 百度学术
    4. 伍世端，张旗炘，梁燕梅，梁惠虹. 围绝经期宫颈上皮内瘤变合并阴道上皮内瘤变的相关高危因素分析. 中国医药科学. 2022(14): 122-125 . 百度学术
    5. 卢国英，付汐，吴彬. 阴道镜下宫颈活检病理诊断宫颈鳞状上皮内病变的价值研究. 中国社区医师. 2022(26): 67-69 . 百度学术
    6. 王苏莉，熊锋宝. 胃镜活检病理检查在HGIN患者中的临床价值分析. 现代诊断与治疗. 2022(16): 2441-2444 . 百度学术
    7. 林楠，张英，蔡锦梅. 探讨阴道镜活检诊断宫颈高级别鳞状上皮内病变的价值及影响诊断准确率的相关因素. 实用妇科内分泌电子杂志. 2022(04): 48-50 . 百度学术
    8. 石鑫，宋风丽，史伟，郅玲玲，贺笑茜，于帅，马丽丽，高万里. 阴道镜下宫颈活检对HSIL和宫颈浸润癌的诊断价值及宫颈浸润癌漏诊的影响因素. 医学综述. 2021(10): 2035-2039 . 百度学术
    9. 李兴中. 阴道镜联合LEEP术对宫颈上皮内瘤变的临床诊疗价值研究. 智慧健康. 2021(20): 92-94 . 百度学术
    10. 张勇，张宏鹁. 宫颈鳞状上皮肿瘤的病理诊断效果. 黑龙江中医药. 2021(04): 103-104 . 百度学术
    11. 顾静凤，张菊平. 阴道镜及活组织检查对早期宫颈上皮内瘤变诊断价值的分析. 中国卫生标准管理. 2021(21): 26-29 . 百度学术
    12. 涂萍，付杰娇. 阴道镜下宫颈环形电切术治疗宫颈低级别鳞状上皮内病变患者的临床效果. 医疗装备. 2021(22): 75-76 . 百度学术
    13. 毛莉，王俊. 阴道镜下宫颈活检对宫颈病变的诊断价值. 中国实用医刊. 2020(16): 53-55 . 百度学术
    14. 高祖标，叶小凤，林思瑶. HSIL患者LEEP术后2年复发Logistic回归分析. 中国病案. 2020(10): 84-87 . 百度学术

    其他类型引用(1)

    • 资源附件(0)
计量
  • 文章访问数:  122
  • HTML全文浏览量:  17
  • PDF下载量:  14
  • 被引次数: 15
出版历程
  • 发布日期:  2005-11-30

目录

摘要
HTML全文
    参考文献(21)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    © 2020 《实用临床医药杂志》编辑部

    地址：江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室邮编：225009电话：0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    x 关闭 永久关闭